Prompt 1:
<|im_start|>system
You are an expert reasoner with extensive experience in all areas. You approach problems through systematic thinking and rigorous reasoning. Your response should reflect deep understanding and precise logical thinking, making your solution path and reasoning clear to others. Please put your thinking process within <think>...</think> tags.<|im_end|>
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: The CYP P450 genes are involved in the formation and breakdown (metabolism) of various molecules and chemicals within cells. Specifically, CYP1A2 localizes to the endoplasmic reticulum and its expression is induced by some polycyclic aromatic hydrocarbons (PAHs), some of which are found in cigarette smoke. It is able to metabolize some PAHs to carcinogenic intermediates. Other xenobiotic substrates for this enzyme include caffeine, aflatoxin B1, and acetaminophen.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit CYP1A2 (B) inhibits CYP1A2
Drug SMILES: <SMILES>O=C(O)[C@H](Cc1cnc[nH]1)N1C(=O)c2ccccc2C1=O</SMILES>
Please think step by step and then put ONLY your final choice ((A) or (B)) after "Answer:"<|im_end|>
<|im_start|>assistant
<think>


GT lable: 0
================================================================================

Reasoning 1:
Parse SMILES:
The drug contains a pyrrole ring (C1=CC=CN1) attached to a chiral carbon, which is connected to a carboxylic acid group and a diketopiperazine-like moiety. The presence of the pyrrole ring is a key structural feature.
Identify Functional Groups:
The pyrrole ring is a five-membered aromatic heterocycle with one nitrogen atom. It is a known substrate for CYP1A2. Other functional groups include the carboxylic acid, which may influence solubility and bioavailability.
Predict Interaction with CYP1A2:
CYP1A2 is a cytochrome P450 enzyme that metabolizes various substrates, including pyrrole. The pyrrole ring in the drug is likely to be metabolized by CYP1A2, leading to its degradation and potential loss of activity.
Final Answer:
(A)
 </think>
Answer: (A)

GT lable 1: 0
================================================================================
================================================================================

Reasoning 2:
Parse SMILES:
The input SMILES is O=C(O)[C@H](Cc1cnc[nH]1)N1C(=O)c2ccccc2C1=O. It contains a carboxylic acid group, a chiral center, a pyrrole ring (Cc1cnc[nH]1), and a succinimide ring (N1C(=O)c2ccccc2C1=O).
Identify Functional Groups:
The pyrrole ring (C1=CC=CN1) contains a secondary amine (-NH-) functional group. The succinimide ring is an imide functional group. The molecule also has a carboxylic acid group (-COOH) and a chiral center.
Predict Interactions with CYP1A2:
The secondary amine of the pyrrole ring can act as a hydrogen bond donor and acceptor, which may interact with the CYP1A2 enzyme. The imide and carboxylic acid groups are generally less reactive in this context. The pyrrole ring is a heterocyclic aromatic system, and its interaction with CYP1A2 could lead to inhibition by binding or metabolic modification.
Construct Hypothesis:
Based on the presence of the pyrrole ring and its nitrogen atom, it is reasonable to hypothesize that the drug molecule can inhibit CYP1A2. The nitrogen in the pyrrole ring can participate in hydrogen bonding with the enzyme, potentially reducing its activity or binding affinity.
Final Answer:
(B)
 </think>
Answer: (B)

GT lable 2: 0
================================================================================
================================================================================

Reasoning 3:
Parse SMILES:
The molecule contains a pyrrole ring (c1cnc[nH]1) attached to a chiral carbon, which is part of an N-aryl succinimide derivative (N1C(=O)c2ccccc2C1=O). The pyrrole ring has an -NH group, which can act as a hydrogen bond donor.
Identify Functional Groups:
The pyrrole ring in the drug is a potential site for CYP1A2 inhibition. The -NH group in pyrrole is a hydrogen bond donor. The succinimide moiety is a rigid, planar structure that might contribute to binding but is less likely to be the primary site of inhibition.
Predict Mechanism:
CYP1A2 inhibitors often interact with the enzyme's active site via hydrogen bonding (e.g., with the -NH group of pyrrole) and hydrophobic interactions. The pyrrole ring, with its hydrogen bond-donating capability, is a plausible scaffold for such interactions.
The provided SMILES describes a molecule with a pyrrole ring. The -NH group in the pyrrole can form hydrogen bonds with the CYP1A2 enzyme, indicating potential inhibition.
Final_SMILES:
O=C(O)[C@H](Cc1cnc[nH]1)N1C(=O)c2ccccc2C1=O
Answer:
B
 </think>
Answer: B

GT lable 3: 0
================================================================================
================================================================================

Reasoning 4:
Parse SMILES:
The drug SMILES is O=C(O)[C@H](Cc1cnc[nH]1)N1C(=O)c2ccccc2C1=O. It contains a pyrrole ring (Cc1cnc[nH]1), a propanoic acid group (O=C(O)[C@H]), and an isoindole-1,3-dione moiety (N1C(=O)c2ccccc2C1=O). The pyrrole is a 5-membered aromatic heterocycle with one nitrogen atom.
Identify Functional Groups:
The key functional groups involved are the pyrrole ring (aromatic heterocycle), the carboxylic acid group, and the isoindole-1,3-dione ring system. The pyrrole ring is a potential binding site for various interactions.
Predict Interactions with CYP1A2:
The pyrrole ring (C1=CC=CN1) in the drug molecule is a 5-membered aromatic system. CYP1A2, being a cytochrome P450 enzyme, can interact with aromatic systems. The pyrrole's aromaticity and hydrogen-bonding capability (due to the [nH] group) may allow for interactions with the enzyme's hydrophobic pockets or catalytic site. While the specific binding outcome to inhibition or not inhibition is not determined by the SMILES alone, the presence of the pyrrole ring indicates potential for interaction with CYP1A2.
The carboxylic acid group (O=C(O)) is ionized at physiological pH, which may reduce membrane permeability but does not preclude interaction with the target enzyme if the binding site is accessible.
The isoindole-1,3-dione moiety is a rigid, planar structure that may contribute to binding but is not directly relevant to the question of inhibition or non-inhibition of CYP1A2 by the pyrrole.
Final_SMILES:
O=C(O)[C@H](Cc1cnc[nH]1)N1C(=O)c2ccccc2C1=O
Final_Answer:
B
 </think>
Answer: B

GT lable 4: 0
================================================================================
================================================================================

Reasoning 5:
<think>
Parse SMILES:
The SMILES string contains a carboxylic acid group (O=C(O)), a chiral center bonded to a pyrrole-containing group (Cc1cnc[nH]1), and an N-substituted phthalimide (N1C(=O)c2ccccc2C1=O). The pyrrole ring (c1cnc[nH]1) includes an [nH] group, which is a potential hydrogen bond donor and acceptor.
Identify Functional Groups:
Key functional groups include: 1. Carboxylic acid (-COOH). 2. Pyrrole ring (azole) with an N-H group. 3. Phthalimide moiety (imide group). The pyrrole nitrogen ([nH]) is a primary reactive site.
Predict Interactions with CYP1A2:
CYP1A2 is an aromatic ring-hydrogenating enzyme. The pyrrole ring in the substrate is a 5-membered aromatic heterocycle. Substitution at the pyrrole nitrogen or direct interactions with the pyrrole ring could potentially affect CYP1A2 activity. The pyrrole nitrogen ([nH]) might act as a hydrogen bond donor or acceptor, influencing binding or catalysis.
Construct Hypothesis:
The presence of the pyrrole ring ([nH]) in the substrate is predicted to inhibit CYP1A2. This could be due to steric/electronic effects of the pyrrole nitrogen disrupting optimal binding to the enzyme's active site, or through an off-target interaction involving the [nH] group.
Final Answer:
(B)
 </think>
Answer: (B)

GT lable 5: 0
================================================================================
================================================================================

Reasoning 6:
Parse SMILES:
The input SMILES contains a central chiral carbon attached to: 1) a carboxylic acid group (O=C(O)), 2) a benzyl group substituted with a pyrrole ring (Cc1cnc[nH]1), and 3) a succinimide ring (N1C(=O)c2ccccc2C1=O). The pyrrole (azole) and succinimide groups are aromatic and polar functionalities.
Identify Functional Groups:
The pyrrole ring (c1cnc[nH]1) is a 5-membered aromatic heterocycle with one nitrogen atom. The succinimide ring (N1C(=O)c2ccccc2C1=O) is a 5-membered lactam ring containing two carbonyl groups. The molecule also contains a carboxylic acid group. These groups are generally polar and can participate in hydrogen bonding.
Predict CYP1A2 Interaction:
CYP1A2 is a cytochrome P450 enzyme that catalyzes the oxidation of various substrates. These substrates typically include aromatic rings, especially polycyclic aromatic hydrocarbons, and other heteroaromatic systems. The enzyme's active site is generally hydrophobic and aromatic interactions are favored for binding.
The pyrrole ring in the input molecule is a weakly electron-rich aromatic system but lacks strong π-π stacking capability due to its small size and non-planar nature. The succinimide and carboxylic acid groups are highly polar and may reduce membrane permeability and hinder interactions with the hydrophobic binding pocket of CYP1A2.
Therefore, the molecule is unlikely to effectively inhibit CYP1A2. The lack of a strong aromatic heterocycle (e.g., quinoline, benzo[h]quinoline, or a substituted benzene) limits its ability to form favorable π-π interactions with the enzyme.
Final Answer: A
 </think>
Answer: A

GT lable 6: 0
================================================================================
================================================================================

Reasoning 7:
Parse SMILES:
The drug molecule contains a carboxylic acid group (O=C(O)), an amino acid-like chiral center ([C@H]), an imidazole ring (c1cnc[nH]1), and a phthalimide ring system (N1C(=O)c2ccccc2C1=O). The imidazole ring is a 5-membered aromatic heterocycle with two nitrogen atoms.
Identify Functional Groups:
The imidazole ring (c1cnc[nH]1) is a heteroaromatic system with a nucleophilic nitrogen atom. The carboxylic acid group (O=C(O)) is ionizable and can engage in hydrogen bonding. The phthalimide moiety (N1C(=O)c2ccccc2C1=O) is a cyclic imide, contributing to rigidity and potential binding interactions.
Predict CYP1A2 Inhibition:
CYP1A2 is an enzyme that metabolizes polycyclic aromatic hydrocarbons and other substrates. Its active site typically requires a basic nitrogen for binding to the substrate's electrophilic aromatic system. The imidazole ring in the drug contains one basic nitrogen ([nH]) that could potentially interact with CYP1A2. However, the imidazole ring is relatively small and may not optimally fill the hydrophobic pocket of the enzyme. Additionally, the presence of the carboxylic acid group could reduce blood-brain barrier permeability, potentially limiting target engagement.
Construct Hypothesis:
The imidazole ring in the drug molecule may provide a weak interaction with the CYP1A2 active site, but its small size and limited hydrophobic surface area likely hinder strong binding. The carboxylic acid group may also reduce membrane permeability, further decreasing the drug's ability to effectively inhibit the enzyme.
Final Answer:
A
 </think>
Answer: A

GT lable 7: 0
================================================================================
================================================================================

Reasoning 8:
Parse SMILES:
The input SMILES string represents a molecule containing a carboxylic acid group (O=C(O)), a chiral center, an imidazole ring (c1cnc[nH]1, which is 1H-imidazole), and a succinimide group (N1C(=O)c2ccccc2C1=O). The imidazole ring is a 5-membered heterocycle with two nitrogen atoms.
Identify Functional Groups:
The key functional group for the imidazole ring is the pyrrole-like N-H (secondary amine) group, which is the primary site for electrophilic aromatic substitution. The succinimide and carboxylic acid groups are generally not involved in direct interactions with CYP1A2.
Predict Interaction with CYP1A2:
CYP1A2 is a cytochrome P450 enzyme that catalyzes the oxidation of various aromatic and heteroaromatic compounds. The imidazole ring in the molecule is an electron-rich heteroaromatic system. Pyrrole N-H groups are common sites for electrophilic attack by cytochrome P450. Therefore, the imidazole ring is likely to be oxidized by CYP1A2. This implies that the molecule undergoes metabolism by CYP1A2 rather than inhibiting the enzyme.
Conclusion:
The presence of the 1H-imidazole ring (c1cnc[nH]1) in the molecule means that CYP1A2 will likely oxidize this ring. As a result, the molecule is a substrate for CYP1A2, and it does not inhibit the enzyme. The given answer (B) suggests that the molecule does inhibit CYP1A2, which is inconsistent with the typical reactivity of imidazole towards CYP1A2.
Final Answer: A
 </think>
Answer: A

GT lable 8: 0
================================================================================
================================================================================

Reasoning 9:
Parse SMILES:
The input SMILES is O=C(O)[C@H](Cc1cnc[nH]1)N1C(=O)c2ccccc2C1=O. It contains a pyrrole ring (Cc1cnc[nH]1), a carboxylic acid group (O=C(O)), and a phthalimide moiety (N1C(=O)c2ccccc2C1=O).
Identify Functional Groups:
The pyrrole ring is an aromatic heterocycle. The carboxylic acid is a polar, ionizable group. The phthalimide is a cyclic imide, contributing to rigidity and hydrogen bonding.
Predict CYP1A2 Interaction:
The pyrrole ring in the SMILES is a pyrrol-1-yl group. While pyrrole derivatives can exhibit binding affinity, the specific isomer (pyrrol-1-yl vs. pyrrol-2-yl, etc.) and its substituents critically influence CYP1A2 interaction. The provided SMILES corresponds to a pyrrol-1-yl group attached to a methylene bridge, which may not optimally engage the hydrophobic pocket or hydrogen bonding sites of CYP1A2.
Final Answer:
(A)
 </think>
Answer: (A)

GT lable 9: 0
================================================================================
================================================================================

Reasoning 10:
Parse SMILES:
The drug molecule contains a pyrrole ring (5-membered aromatic heterocycle with one nitrogen) attached to a chiral carbon, which is part of a larger structure consisting of a carboxylic acid, an amide, and a lactam.
Identify Functional Groups:
The pyrrole ring (c1cnc[nH]1) is a key functional group. The molecule also contains a carboxylic acid (-COOH), amide (-CONH-), and lactam (cyclic amide) groups.
Predict Interaction with CYP1A2:
CYP1A2 is a cytochrome P450 enzyme that catalyzes the conversion of a substrate (R) to a product (R'). The SMILES notation implies an R-CH₂-N(R') structure, where the chiral carbon is directly bonded to the pyrrole ring, a hydrogen, the methylene bridge (CH₂), and the N-substituted amide/lactam. The pyrrole's aromaticity and lack of strong electron-withdrawing groups may limit its ability to stabilize the transition state or the R product during CYP1A2 catalysis. The chiral center could also lead to steric clashes.
Final Answer:
A
 </think>
Answer: A

GT lable 10: 0
================================================================================
================================================================================

Reasoning 11:
Parse SMILES:
The drug contains a carboxylic acid group, a chiral center, an imidazole ring, and a phthalimide (isoindole-1,3-dione) moiety. The imidazole is connected to a methylene bridge and the chiral center. The phthalimide is linked to the nitrogen of the chiral center.
Identify Functional Groups:
Key functional groups include the carboxylic acid (-COOH), the chiral center, the imidazole ring (c1cnc[nH]1), and the phthalimide system (N1C(=O)c2ccccc2C1=O). The imidazole is a 5-membered heterocycle with two nitrogens; one is a pyrrole-like NH.
Predict CYP1A2 Inhibition:
The imidazole ring (c1cnc[nH]1) is a potential site for CYP1A2 inhibition. Imidazole derivatives can act as enzyme inhibitors, and the NH group may participate in hydrogen bonding. The electron-rich nature of imidazole could also interfere with the electron-deficient environment of the CYP1A2 active site.
Construct Hypothesis:
The imidazole ring in the molecule is likely to inhibit CYP1A2. This is a common pharmacophore for CYP1A2 inhibition, and the NH group can form hydrogen bonds with the enzyme. The rest of the molecule, including the carboxylic acid and phthalimide, is less likely to interfere with the target.
Final Answer:
(B)
 </think>
Answer: (B)

GT lable 11: 0
================================================================================
================================================================================

Reasoning 12:
Parse SMILES:
The drug SMILES is O=C(O)[C@H](Cc1cnc[nH]1)N1C(=O)c2ccccc2C1=O. It contains a chiral center with an amino acid-like side chain (with a pyrrole group), a carboxylic acid group, and a phthalimide ring system.
Identify Functional Groups:
Key functional groups include: a carboxylic acid (-COOH), a pyrrole ring (aromatic heterocycle with NH), and an imide group (part of the phthalimide ring). The pyrrole nitrogen is part of an aromatic system and not a typical hydrogen-bond donor/acceptor.
Predict Target Binding:
The drug molecule is unlikely to inhibit CYP1A2. The carboxylic acid group, while potentially ionizable, is unlikely to form strong hydrogen bonds or charge interactions with the hydrophobic binding pocket of CYP1A2. The pyrrole ring lacks hydrogen-bond donors and its aromaticity may reduce adaptability to the target. The molecule's overall hydrophilicity (due to the carboxylic acid) may hinder membrane permeability and binding.
Conclusion:
The carboxylic acid group is too hydrophilic and not a common pharmacophore for CYP1A2 inhibition. The rigid phthalimide ring and aromatic pyrrole may also limit optimal binding interactions. Therefore, the drug is predicted to not inhibit CYP1A2.
Answer: A
 </think>
Answer: A

GT lable 12: 0
================================================================================
================================================================================

Reasoning 13:
Parse SMILES:
The drug SMILES is O=C(O)[C@H](Cc1cnc[nH]1)N1C(=O)c2ccccc2C1=O. It contains a carboxylic acid group, a chiral center, an imidazole ring (Cc1cnc[nH]1), an amino group, and a phthalimide scaffold (N1C(=O)c2ccccc2C1=O).
Identify Functional Groups:
The imidazole ring (Cc1cnc[nH]1) is a 5-membered heterocycle with two nitrogen atoms. One nitrogen is part of an aromatic system (imidazole), and the other is an NH group. The rest of the molecule includes a carboxylic acid and a phthalimide.
Predict Interactions with CYP1A2:
CYP1A2 is a cytochrome P450 enzyme that metabolizes various substrates, including imidazoles. The NH group of the imidazole ring can act as a nucleophile or hydrogen bond donor, potentially reacting with the electrophilic or oxidizing environment of the CYP1A2 active site. This interaction could lead to metabolism of the imidazole moiety.
Construct Hypothesis:
The presence of the imidazole ring (specifically its NH group) in the drug molecule is likely to result in its metabolism by CYP1A2. This means that the imidazole portion of the molecule would be modified or broken down by the enzyme, leading to a change in the drug's properties or activity.
Final Answer:
(B)
 </think>
Answer: (B)

GT lable 13: 0
================================================================================
================================================================================

Reasoning 14:
Parse Reactants/Reagents:
Reactant 1 (Substrate for CYP1A2): O=C(O)[C@H](Cc1cnc[nH]1)N1C(=O)c2ccccc2C1=O. Reactant 2 (CYP1A2): CYP1A2 enzyme, a cytochrome P450 monooxygenase.
Identify Functional Groups:
Substrate: Carboxylic acid (-COOH), chiral center, imidazole-like aromatic system (Cc1cnc[nH]1), phthalimide moiety (N1C(=O)c2ccccc2C1=O). CYP1A2: P450 cytochrome system (oxidized form with a protonatable nitrogen).
Predict Reaction Type:
CYP1A2-mediated metabolism of the substrate. The CYP1A2 enzyme will oxidize the substrate's electron-rich regions (e.g., the imidazole-like system, or the -CH2- bridge between the chiral center and the imidazole) or participate in an electrophilic aromatic substitution on the imidazole. This results in the formation of a metabolite.
Construct Product Structure:
The substrate molecule O=C(O)[C@H](Cc1cnc[nH]1)N1C(=O)c2ccccc2C1=O undergoes oxidation by CYP1A2. A common site of metabolism for such molecules is the C-H bond adjacent to the nitrogen atoms in the imidazole-like ring (specifically, the C-H in the -Cc1cnc[nH]1 fragment). This C-H bond is oxidized to a C=O group. The original -CH2-imidazole moiety (represented as Cc1...) becomes -C(=O)-imidazole (represented as C(=O)c1...). The rest of the molecule remains unchanged.
Final_SMILES:
O=C(O)[C@H](C(=O)c1cnc[nH]1)N1C(=O)c2ccccc2C1=O
Answer: (A)
 </think>
Answer: (A)

GT lable 14: 0
================================================================================
================================================================================

Reasoning 15:
Parse SMILES:
The drug SMILES is O=C(O)[C@H](Cc1cnc[nH]1)N1C(=O)c2ccccc2C1=O. It contains a pyrrole ring (Cc1cnc[nH]1), a carboxylic acid group (O=C(O)), and an isoindole-1,3-dione moiety (N1C(=O)c2ccccc2C1=O).
Identify Functional Groups:
Key functional groups include the pyrrole ring (a 5-membered heteroaromatic ring with nitrogen), carboxylic acid, and a diketopiperazine-like structure (isoindole-1,3-dione).
Predict Drug-Target Interactions:
The pyrrole ring might participate in hydrogen bonding or π-π interactions. The carboxylic acid could influence solubility and binding. The isoindole-1,3-dione moiety is potentially reactive or could participate in binding. The molecule overall has moderate polarity due to the carboxylic acid and amide functionalities.
Construct Hypothesis:
The molecule does not exhibit strong inhibition of CYP1A2. The pyrrole ring, while potentially reactive, does not significantly hinder the enzyme's activity. The carboxylic acid group might cause poor membrane permeability, reducing bioavailability. The isoindole-1,3-dione moiety is not a known site for CYP1A2 inhibition.
Final Answer:
A
 </think>
Answer: A

GT lable 15: 0
================================================================================
================================================================================

Reasoning 16:
Parse SMILES:
The SMILES is O=C(O)[C@H](Cc1cnc[nH]1)N1C(=O)c2ccccc2C1=O. It contains a carboxylic acid group, a chiral carbon attached to an imidazole ring (via a methylene bridge), and an N-substituted phthalimide group.
Identify Functional Groups:
Key functional groups include: carboxylic acid (O=C(O)), imidazole (c1cnc[nH]1), and a phthalimide moiety (N1C(=O)c2ccccc2C1=O). The imidazole is a heterocyclic aromatic system with potential hydrogen-bonding capability.
Predict Reaction Type:
The molecule is predicted to interact with CYP1A2, a cytochrome P450 enzyme. The imidazole ring and the carboxylic acid group are likely to participate in binding interactions. The imidazole, being an electron-rich heterocycle, can engage in π-π stacking or hydrogen bonding with the enzyme. The carboxylic acid could influence solubility and binding via ionization or hydrogen bonding.
Construct Hypothesis:
The imidazole ring in the molecule is a known pharmacophore for binding to CYP1A2. Given the presence of this group and the structural similarity to known CYP1A2 inhibitors (e.g., Imidazole derivatives like C2H12N2, which can be represented as C[nH]cn), it is highly likely that this molecule inhibits CYP1A2. The stereochemistry at the chiral carbon might also influence binding, but the presence of the imidazole is the primary indicator.
Final Answer:
(B)
 </think>
Answer: (B)

GT lable 16: 0
================================================================================
